ProQR Therapeutics N.V. (PRQR)

ProQR Therapeutics Revenue

ProQR Therapeutics had revenue of $14.66M in the twelve months ending March 31, 2024, with 252.63% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $5.07M with 568.58% year-over-year growth. In the year 2023, ProQR Therapeutics had annual revenue of $10.58M with 128.23% growth.

• Revenue (ttm): $14.66M
• Revenue Growth: +252.63%
• P/S Ratio: 9.16
• Revenue / Employee: $93,980
• Employees: 156
• Market Cap: 134.33M USD

Revenue Chart

* The company reports in EUR currency but revenue data is shown in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	10.58M	5.95M	128.23%
Dec 31, 2022	4.64M	1.93M	71.60%
Dec 31, 2021	2.70M	-8.82M	-76.56%
Dec 31, 2020	11.53M	9.35M	430.72%
Dec 31, 2019	2.17M	-4.45M	-67.20%
Dec 31, 2018	6.62M	4.83M	269.10%
Dec 31, 2017	1.79M	-129.73K	-6.74%
Dec 31, 2016	1.92M	-1.59M	-45.25%
Dec 31, 2015	3.51M	3.13M	827.78%
Dec 31, 2014	378.71K	219.19K	137.41%
Dec 31, 2013	159.52K	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.